NCT02031861View on ClinicalTrials.gov

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Essential Hypertension

Interventions

DRUG

nifedipine CR tablets (Xin Ran)

DRUG

nifedipine CR tablets (Adalat)

Trial Locations (1)

200025

Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School, Shanghai

All Listed Sponsors

lead

Shanghai Shyndec Pharmaceutical Co., Ltd.

INDUSTRY

NCT02031861 - Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension | Biotech Hunter | Biotech Hunter